Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.
Some diabetes meds might lower risk of dementia, Parkinson's
People prescribed SGLT2 inhibitors were compared with people taking other oral diabetes drugs. Alzheimer's disease among people on SGLT2 inhibitors was just under 40 cases per 10,000 person-years ...
Reverse Type 2 Diabetes Without Medication with Dr. Kathleen Nash
Dr. Kathleen Nash shares how to potentially reverse Type 2 diabetes naturally, without medication, through metabolic changes based on her personal 80-pound weight loss journey. #PaidForContent
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study. A class of drugs for diabetes may be associated with a lower risk ...
Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's
A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream and excrete it in urine,
Medical News Today2h
Common diabetes drug may help slow organ aging, monkey study shows
The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...
ScienceAlert on MSN2d
Common Diabetes Medication Slows Brain Aging in Monkeys
Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
Revealing New DNA Structures: A Breakthrough That Could Redefine Diabetes Treatment
Researchers discovered the crystal structure of an alternative DNA configuration within the insulin gene, providing insights ...
News Medical13d
Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing
Research shows elevated metformin in diabetic foot ulcer exudates when combined with insulin, highlighting potential for ...
Study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...